Altius Strategy Consulting

Reaching higher goals in healthcare


Altius Strategy Consulting helps companies plan for successful pricing, reimbursement, market access and adoption of medical products through the creation and demonstration of product value. 

Altius specializes in a multidisciplinary approach to product analyses that integrates scientific, clinical, regulatory, health economic, health-related quality of life, and market information. 

Altius works closely with its clients’ senior teams, providing insights and advice to inform product and service development decisions.

Altius understands the increasingly demanding evidence requirements of market stakeholders. It incorporates this understanding into its strategic assessments, creating effective commercialization strategies and value development plans for products in late preclinical and clinical development.


Altius Strategy Consulting helps its clients attain higher goals in addressing

critical unmet medical needs through product Value Development Planning.

News / Events:

May 22 - 24, 2017 Altius attends the ISPOR 22nd Annual International Meeting in Boston

April 21, 2017 Video recording of the MassBio Annual Meeting plenary session “Biotech in the Era of Real World Evidence” now available on the Altius Events webpage

March 30, 2017 Altius Principal, Leora Schiff moderates plenary session on Biotech in the Era of Real World Evidence at the MassBio Annual Meeting

March 29, 2017 Timmerman Report publishes article by Altius Principal, Leora Schiff on Trump policies that can affect the healthcare industry

March 20, 2017 Altius Principal, Leora Schiff moderates a panel of US and EU policy experts on the potential impact of Trump Administration policies on the biopharm industry at BioEurope Spring

March 14, 2017 EyeForPharma article quotes Altius Principal, Leora Schiff’s comments from expert roundtable on Value-based Contracting in Oncology

© Altius Strategy Consulting 2017